Breaking News Instant updates and real-time market news.

MLM

Martin Marietta

$201.51

-4.39 (-2.13%)

, DHI

D.R. Horton

$49.71

-0.53 (-1.05%)

08:38
12/07/17
12/07
08:38
12/07/17
08:38

Deutsche Bank to hold a conference

Homebuilding & Building Products Strategic Value Creation Conference is being held in New York on December 7.

MLM

Martin Marietta

$201.51

-4.39 (-2.13%)

DHI

D.R. Horton

$49.71

-0.53 (-1.05%)

TOL

Toll Brothers

$46.68

-0.25 (-0.53%)

SITE

SiteOne Landscape

$70.62

-1.3 (-1.81%)

LGIH

LGI Homes

$67.15

0.31 (0.46%)

DB

Deutsche Bank

$18.50

-0.26 (-1.39%)

  • 07

    Dec

  • 13

    Dec

MLM Martin Marietta
$201.51

-4.39 (-2.13%)

10/11/17
JEFF
10/11/17
INITIATION
Target $240
JEFF
Buy
Martin Marietta assumed with a Buy at Jefferies
Jefferies analyst Philip Ng assumed coverage of Martin Marietta with a Buy rating and $240 price target. The company offers "reasonable value for the quality of the assets and strong underlying fundamental," the analyst contends.
06/29/17
LBOW
06/29/17
NO CHANGE
LBOW
Cement checks positive, says Longbow
After conducting a survey, Longbow analyst Garik Shmois says the "very strong" volume outlook supports his view that cement sales will jump by mid to high single digit percentage levels in 2H17. He keeps Buy ratings on CEMEX (CX), Martin Marietta (MLM), and Summit Materials (SUM). He keeps a Neutral rating on Eagle Materials (EXP).
08/02/17
STFL
08/02/17
NO CHANGE
STFL
Martin Marietta Q2 miss creates buying opportunity, says Stifel
After Martin Marietta's Q2 results came in below expectations, Stifel analyst Stanley Elliott says the miss was "largely" caused by weather. The analyst expects the company's 2018 EBITDA to increase 20% excluding acquisitions and he thinks the stock's decline creates a buying opportunity.
11/03/17
DADA
11/03/17
NO CHANGE
Target $225
DADA
Neutral
Martin Marietta price target lowered to $225 from $235 at DA Davidson
DA Davidson Brent Thielman lowered his price target on Martin Marietta to $225 and kept his Neutral rating. Thielman says the company will need to show whether easy comps, stable weather and public sector momentum can carry the weight of mid-single digit volume growth guidance in FY18. While the analyst notes some improved activity in Texas and Iowa, he is reducing his price target based on stronger than anticipated challenges of the past year's second half.
DHI D.R. Horton
$49.71

-0.53 (-1.05%)

11/10/17
ZELM
11/10/17
DOWNGRADE
ZELM
Hold
D.R. Horton downgraded to Hold from Buy at Zelman
10/23/17
WELS
10/23/17
NO CHANGE
Target $62
WELS
Outperform
D.R. Horton price target raised to $62 from $41 at Wells Fargo
Wells Fargo raised its price target for D.R. Horton to $62 from $41 on valuation. The analyst reiterates an Outperform rating on the shares.
10/25/17
UBSW
10/25/17
INITIATION
Target $50
UBSW
Buy
D.R. Horton initiated with a Buy at UBS
UBS analyst Daniel Oppenheim started D.R. Horton with a Buy rating and $50 price target. The analyst expects the company to benefit from the recovery of entry-level new home sales.
11/21/17
BOFA
11/21/17
NO CHANGE
BOFA
D.R. Horton added to US 1 List, Mohawk, Comcast removed at BofA/Merrill
TOL Toll Brothers
$46.68

-0.25 (-0.53%)

12/07/17
RAJA
12/07/17
DOWNGRADE
Target $52
RAJA
Outperform
Toll Brothers downgraded to Outperform from Strong Buy at Raymond James
Raymond James analyst Buck Horne downgraded Toll Brothers to Outperform and raised its price target to $52 from $43 following Q4 results and guidance. The analyst said FY18 gross margins are more cautious than expected due to New York City headwinds ahead of an upcoming supply wave. Further, there is a timing delay of community openings that will lower active store count and headline risks from tax reform plans that could hurt job growth in high-cost states. Buck remains constructive on Toll shares given "outstanding demand trends" and absorption.
12/06/17
12/06/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Toll Brothers (TOL) downgraded to Sector Weight from Overweight at KeyBanc with analyst Kenneth Zener citing the company's fourth quarter results. 2. Chemours (CC) downgraded to Neutral from Buy at Goldman Sachs with analyst Robert Koort citing a moderating view for TiO2 pricing. 3. Patterson Cos (PDCO) and Henry Schein (HSIC) were downgraded to Underweight from Equal Weight at Morgan Stanley. 4. AutoZone (AZO) downgraded to Neutral from Buy at Guggenheim with analyst Steven Forbes citing balanced risk/reward following the recent share rally. 5. Edison International (EIX) downgraded to Neutral from Buy at Mizuho. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/06/17
UBSW
12/06/17
NO CHANGE
Target $53
UBSW
Buy
Toll Brothers share price decline overdone, says UBS
UBS analyst Daniel Oppenheim noted Toll Brothers shares fell 7.4% following the release of Q4 results and he believes the decline is overdone. The analyst believes the company is well positioned heading into 2018 and investors should focus on its year-over-year increase in absorption, which is a testament to its strength in demand rather than on the timing issue of three high-price-point City Living condo units. Oppenheim reiterated his Buy rating and raised his price target to $53 from $50 on Toll Brothers shares.
12/06/17
WELS
12/06/17
NO CHANGE
Target $54
WELS
Outperform
Toll Brothers price target raised to $54 from $42 at Wells Fargo
Wells Fargo raised its price target for Toll Brothers to $54 from $42 as he believes 2018 consensus must come up, and sees EPS growth in the high teens as rational, with upside potential from repurchases and margins. The firm reiterates an Outperform rating on the shares as he sees value versus peers and versus history.
SITE SiteOne Landscape
$70.62

-1.3 (-1.81%)

11/09/17
RHCO
11/09/17
NO CHANGE
Target $70
RHCO
Buy
SiteOne Landscape price target raised to $70 from $59 at SunTrust
SunTrust analyst Keith Hughes raised his price target on SiteOne Landscape to $70 and kept his Buy rating after Q3 results. Hughes says that despite the earnings miss, the fundamental story on the stock has not changed, as he continues to expect the company to benefit from organic growth, acquisition growth and margin leverage. The analyst also notes that hurricane activity weighed on organic sales growth in September, but management believes that Q4 has seen some improvement.
11/09/17
BARD
11/09/17
NO CHANGE
Target $74
BARD
Outperform
SiteOne Landscape price target raised to $74 from $58 at Baird
Baird analyst David Manthey raised his price target on SiteOne Landscape to $74 from $58 citing expectations for an improving organic growth rate, continued gross margin gains, and meaningful SG&A leverage. The analyst believes this is the start of a long period of value creation and would use any weakness as a buying opportunity. Manthey reiterated his Outperform rating on SiteOne Landscape shares.
05/08/17
JRCO
05/08/17
INITIATION
JRCO
Accumulate
SiteOne Landscape initiated with an Accumulate at Johnson Rice
08/10/17
BARD
08/10/17
NO CHANGE
Target $58
BARD
Outperform
SiteOne Landscape remains a top idea, says Baird
Baird analyst David Manthey noted SiteOne Landscape reported strong Q2 earnings and maintained guidance with increasing confidence. He said organic growth accelerated and margins continued to expand while acquisitions continued to augment growth. He rates SiteOne as a top idea and believes this is the start of a long period of value creation. Manthey reiterated his Outperform rating and raised his price target to $58 from $56 on SiteOne Landscape shares.
LGIH LGI Homes
$67.15

0.31 (0.46%)

08/10/17
DBAB
08/10/17
NO CHANGE
Target $55
DBAB
Buy
LGI Homes price target raised to $55 from $40 at Deutsche Bank
Deutsche Bank analyst Nishu Sood raised his price target for LGI Homes to $55 saying the "strong" trends seen in Q2 should continue amid easier lending standards. Further momentum in results is likely in the second half of 2017 and 2018, Sood tells investors in a research note. The analyst keeps a Buy rating on the shares.
10/03/17
WEDB
10/03/17
DOWNGRADE
Target $49
WEDB
Neutral
LGI Homes downgraded to Neutral from Outperform at Wedbush
Wedbush analyst Jay McCanless downgraded LGI Homes to Neutral citing valuation and maintained a $49 price target.
08/31/17
WEDB
08/31/17
UPGRADE
Target $49
WEDB
Outperform
LGI Homes upgraded to Outperform from Neutral at Wedbush
Wedbush analyst Jay McCanless upgraded LGI Homes to Outperform with a $49 price target saying the 15% share decline since early August 8 discounts risk of potential delays in Houston closings. The analyst said sees risks to 2017 earnings as beneficial to 2018 and said mortgage underwriting standards are loosening which should benefit core customer base.
11/08/17
WEDB
11/08/17
NO CHANGE
Target $60
WEDB
Neutral
LGI Homes price target raised to $60 from $55 at Wedbush
Wedbush analyst Jay McCanless raised his price target for LGI Homes to $60 from $55 following quarterly results. The analyst reiterates a Neutral rating on the shares.
DB Deutsche Bank
$18.50

-0.26 (-1.39%)

11/20/17
11/20/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wal-Mart (WMT) downgraded to Neutral from Buy at Goldman Sachs with analyst Matthew Fassler sayign valuation following "powerful" share appreciation now reflects the company's progress in growing earnings. 2. Five Below (FIVE) downgraded to Hold from Buy at Loop Capital with analyst Anthony Chukumba citing valuation. 3. Live Nation (LYV) downgraded to In Line from Outperform at Evercore ISI with analyst David Joyce citing valuation. 4. Monster Beverage (MNST) downgraded to Negative from Neutral at Susquehanna with analyst Pablo Zuanic citing its high valuation, which he believes is misplaced due to assumptions about an offer from Coca-Cola (KO). 5. Deutsche Bank (DB) downgraded to Underperform from Market Perform at Keefe Bruyette. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/20/17
KBWI
11/20/17
DOWNGRADE
KBWI
Underperform
Deutsche Bank downgraded to Underperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst George Karamanos downgraded Deutsche Bank to Underperform.
11/14/17
11/14/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Coca-Cola (KO) upgraded to Outperform from Market Perform at Wells Fargo with analyst Bonnie Herzog saying the shares should be a core holding in 2018 and beyond. 2. Deutsche Bank (DB) upgraded to Buy from Hold at HSBC with analyst Alevizos Alevizakos saying the current valuation seemingly ignores the upside inherent in the bank's improved capital position. 3. Famous Dave's (DAVE) upgraded to Buy from Hold at Craig-Hallum with analyst Alex Fuhrman citing the third quarter results beat, refranchising efforts progressing well and further G&A reductions targeted. 4. ADP (ADP) resumed at Equal Weight, up from Underweight, at Morgan Stanley with analyst Danyal Hussain saying he expects ADP to execute with a greater sense of urgency, but there is still "more work to do" and the proxy fight has put a spotlight on some concerns on which investors will remain focused, including margins and potential share losses, he tells investors. 5. Phoenix New Media (FENG) upgraded to Outperform from Neutral at Macquarie. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/14/17
HSBC
11/14/17
UPGRADE
HSBC
Buy
Deutsche Bank upgraded to Buy from Hold at HSBC
HSBC analyst Alevizos Alevizakos upgraded Deutsche Bank to Buy and raised his price target for the shares to EUR 18 from EUR 14. The current valuation seemingly ignores the upside inherent in the bank's improved capital position, Alevizakos tells investors in a research note. The analyst believes excess capital creates optionality for the Deutsche.

TODAY'S FREE FLY STORIES

FLR

Fluor

$41.39

-2.26 (-5.18%)

16:20
11/20/18
11/20
16:20
11/20/18
16:20
Hot Stocks
Fluor selected for lithium, boron mine project in Nevada »

Fluor Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

TGT

Target

$69.05

-8.08 (-10.48%)

, BBY

Best Buy

$63.54

1.35 (2.17%)

16:20
11/20/18
11/20
16:20
11/20/18
16:20
OnTheFly
Fly Intel: Wall Street's top stories for Tuesday »

Stocks began the session…

TGT

Target

$69.05

-8.08 (-10.48%)

BBY

Best Buy

$63.54

1.35 (2.17%)

CPB

Campbell Soup

$40.57

2.1 (5.46%)

KLIC

Kulicke & Soffa

$21.25

1.345 (6.76%)

A

Agilent

$67.61

5.04 (8.06%)

LIVN

LivaNova

$98.00

-22.28 (-18.52%)

LB

L Brands

$28.43

-6.105 (-17.68%)

AAPL

Apple

$177.10

-8.7 (-4.68%)

BSX

Boston Scientific

$34.05

-1.24 (-3.51%)

NAVI

Navient

$10.74

-1.255 (-10.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 27

    Nov

  • 29

    Nov

  • 04

    Dec

  • 05

    Dec

  • 11

    Dec

  • 03

    Mar

USAT

USA Technologies

$4.96

-0.055 (-1.10%)

16:20
11/20/18
11/20
16:20
11/20/18
16:20
Hot Stocks
USA Technologies provides update on Nasdaq notification of deficiency »

USA Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
11/20/18
11/20
16:20
11/20/18
16:20
Options
Closing CBOE SPX and VIX Index summary for November 20th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNMK

GenMark

$5.01

(0.00%)

16:19
11/20/18
11/20
16:19
11/20/18
16:19
Syndicate
Breaking Syndicate news story on GenMark »

GenMark files $150M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 30

    Nov

CAL

Caleres

$30.93

-1.165 (-3.63%)

16:18
11/20/18
11/20
16:18
11/20/18
16:18
Earnings
Caleres reports Q3 adj. EPS 81c, consensus 88c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

RMBL

RumbleON

$5.76

-0.35 (-5.73%)

16:18
11/20/18
11/20
16:18
11/20/18
16:18
Syndicate
Breaking Syndicate news story on RumbleON »

RumbleON files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 10

    Dec

GPS

Gap

$24.65

-0.79 (-3.11%)

16:18
11/20/18
11/20
16:18
11/20/18
16:18
Earnings
Gap narrows FY18 EPS view to $2.55-$2.60 from $2.55-$2.70, consensus $2.56 »

Backs FY18 SSS view of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

MRCY

Mercury Systems

$46.80

-0.48 (-1.02%)

16:18
11/20/18
11/20
16:18
11/20/18
16:18
Hot Stocks
Mercury Systems gets $6.7M Integrated subsystems order for naval electronics »

Mercury Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRI

Thomson Reuters

$47.83

-0.59 (-1.22%)

16:17
11/20/18
11/20
16:17
11/20/18
16:17
Hot Stocks
Thomson Reuters receives court approval for return of capital transaction »

Thomson Reuters announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

STRM

Streamline Health

$0.90

(0.00%)

, WFC

Wells Fargo

$52.54

-0.77 (-1.44%)

16:17
11/20/18
11/20
16:17
11/20/18
16:17
Hot Stocks
Streamline Health extends banking agreement with Wells Fargo into 2020 »

Streamline Health…

STRM

Streamline Health

$0.90

(0.00%)

WFC

Wells Fargo

$52.54

-0.77 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Apr

  • 13

    Jul

  • 12

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
11/20/18
11/20
16:17
11/20/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$24.65

-0.79 (-3.11%)

16:16
11/20/18
11/20
16:16
11/20/18
16:16
Earnings
Gap reports Q3 EPS 69c, consensus 68c »

Reports Q3 revenue $4.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
11/20/18
11/20
16:16
11/20/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.10

-2.69 (-5.51%)

16:14
11/20/18
11/20
16:14
11/20/18
16:14
Hot Stocks
Breaking Hot Stocks news story on Foot Locker »

Foot Locker up 11% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BJ

BJ's Wholesale

$19.85

-0.22 (-1.10%)

16:13
11/20/18
11/20
16:13
11/20/18
16:13
Hot Stocks
Breaking Hot Stocks news story on BJ's Wholesale »

BJ's Wholesale now…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

FL

Foot Locker

$46.05

-2.74 (-5.62%)

16:13
11/20/18
11/20
16:13
11/20/18
16:13
Hot Stocks
Foot Locker CFO says 'encouraged' by Q3 SSS growth »

"We're…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

HTBX

Heat Biologics

$2.04

0.14 (7.37%)

16:13
11/20/18
11/20
16:13
11/20/18
16:13
Syndicate
Heat Biologics fiels to sell common stock and warrants, no amount given »

A.G.P./Alliance Global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.14

-2.65 (-5.43%)

16:13
11/20/18
11/20
16:13
11/20/18
16:13
Hot Stocks
Foot Locker reports merchandise inventories $1.305B at November 3 »

As of November 3, 2018,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

TWI

Titan International

$6.51

-0.4 (-5.79%)

16:13
11/20/18
11/20
16:13
11/20/18
16:13
Hot Stocks
Titan International receives settlement put option notice »

Titan International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$33.93

-0.69 (-1.99%)

16:12
11/20/18
11/20
16:12
11/20/18
16:12
Hot Stocks
Mylan announces voluntary recall of select lots of Valsartan-containing products »

Mylan announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 04

    Dec

BJ

BJ's Wholesale

$19.83

-0.24 (-1.20%)

16:12
11/20/18
11/20
16:12
11/20/18
16:12
Earnings
BJ's Wholesale raises FY18 adj. EPS view to $1.22-$1.26 from $1.17-$1.24 »

Consensus $1.23. Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

PLG

Platinum Group

$0.16

-0.0116 (-6.64%)

16:12
11/20/18
11/20
16:12
11/20/18
16:12
Hot Stocks
Platinum Group announces reverse 10:1 stock split »

Platinum Group Metals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LFC

China Life Insurance

$10.44

-0.21 (-1.97%)

16:12
11/20/18
11/20
16:12
11/20/18
16:12
Upgrade
China Life Insurance rating change  »

China Life Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$69.11

-8.02 (-10.40%)

16:11
11/20/18
11/20
16:11
11/20/18
16:11
Recommendations
Target analyst commentary  »

Target shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.